{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:53:09Z","timestamp":1793055189530,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPPGH5295"],"award-info":[{"award-number":["OPPGH5295"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Niger has one of the highest maternal mortality ratios in Sub Saharan Africa, of which postpartum hemorrhage is the leading cause. In 2014, Health and Development International and the Ministry of Health of Niger launched an initiative to introduce and scale-up three PPH interventions in health facilities nationwide: misoprostol, uterine balloon tamponade, and the non-pneumatic anti-shock garment.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A two-phase mixed-methods evaluation was conducted to assess implementation of the initiative. Health facility assessments, provider interviews, and household surveys were conducted in May 2016 and November 2017.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All evaluation facilities received misoprostol prevention doses. However, shortages in misoprostol treatment doses, UBT kits, and NASG stock were documented. Health provider training increased while knowledge of each PPH intervention varied. Near-universal uterotonic coverage for PPH prevention and treatment was achieved and sustained throughout the evaluation period. Use of UBT and NASG to manage PPH was rare and differed by health facility type. Among community deliveries, fewer than 22% of women received misoprostol at antenatal care for self-administered prophylaxis. Among those who did, almost all reported taking the drugs for PPH prevention in each phase.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study is the first external evaluation of a comprehensive PPH program taking misoprostol, UBT, and NASG to national scale in a low resource setting. Although gaps in service delivery were identified, results demonstrate the complexities of training, managing stock, and implementing system-wide interventions to reach women in varying contexts. The experience provides important lessons for other countries as they develop and expand evidence-based programs for PPH care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-019-2502-5","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T16:28:29Z","timestamp":1572020909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Scaling up interventions: findings and lessons learned from an external evaluation of Niger\u2019s National Initiative to reduce postpartum hemorrhage"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-366X","authenticated-orcid":false,"given":"Meighan","family":"Mary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayisha","family":"Diop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy R.","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aichatou","family":"Yenikoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"2502_CR1","unstructured":"World Health Organization, UNICEF, United Nations, Department of Economic and Social Affairs, Population Division, World Bank. Trends in maternal mortality: 1990 to 2015\u00a0: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. 2015. Accessed 2019 Apr 22. Available from: \n                    http:\/\/www.who.int\/reproductivehealth\/publications\/monitoring\/maternal-mortality-2015\/en\/"},{"key":"2502_CR2","unstructured":"Institut National de la Statistique. Niger Enqu\u00eate D\u00e9mographique et de Sant\u00e9 et \u00e0 Indicateurs Multiples 2012. EDSN-MICS IV. 2013. Available from: \n                    https:\/\/dhsprogram.com\/publications\/publication-FR277-DHS-Final-Reports.cfm\n                    \n                  . Accessed 13 May 2019."},{"key":"2502_CR3","unstructured":"World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization; 2012. Available from: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/75411\/1\/9789241548502_eng.pdf?ua=1\n                    \n                  . Accessed 22 Nov 2018."},{"key":"2502_CR4","volume-title":"Uterotonics for the prevention of postpartum haemorrhage","author":"WHO recommendations","year":"2018","unstructured":"WHO recommendations. Uterotonics for the prevention of postpartum haemorrhage. Geneva: World Health Organization; 2018."},{"issue":"3","key":"2502_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ijgo.12756","volume":"144","author":"DF Abbas","year":"2019","unstructured":"Abbas DF, Jehan N, Diop A, Durocher J, Byrne ME, Zuberi N, et al. Using misoprostol to treat postpartum hemorrhage in home deliveries attended by traditional birth attendants. Int J Gynecol Obstet. 2019;144(3):290\u20136.","journal-title":"Int J Gynecol Obstet"},{"issue":"6","key":"2502_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1586\/17474108.2013.847622","volume":"8","author":"AM El Ayadi","year":"2013","unstructured":"El Ayadi AM, Robinson N, Geller S, Miller S. Advances in the treatment ofpostpartum hemorrhage. Expert Rev Obstet Gynecol. 2013;8(6):525\u201337.","journal-title":"Expert Rev Obstet Gynecol"},{"key":"2502_CR7","unstructured":"Minist\u00e8re de la Sant\u00e9 Publique, Health and Development International. Protocole de mise en \u0153uvre de l\u2019Initiative de Renforcement de la Lutte contre les H\u00e9morragies du Post Partum (HPP) \u00e0 l\u2019\u00e9chelle nationale par l\u2019usage du misoprostol. Niamey; 2013."},{"key":"2502_CR8","unstructured":"Annuarie des statistiques sanitaires du Niger: Ann\u00e9e 2016. Niamey, Niger: Direction des Statistiques du Minist\u00e8re de la Sant\u00e9 Publique; 2016. Available from: \n                    http:\/\/www.stat-niger.org\/statistique\/file\/Annuaires_Statistiques\/snis\/Annuaire_statistiques_2016.pdf\n                    \n                  . Accessed 18 Sept 2018."},{"key":"2502_CR9","first-page":"CD009336","volume":"2","author":"OT Oladapo","year":"2012","unstructured":"Oladapo OT, Fawole B, Blum J, Abalos E. Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database Syst Rev. 2012;2:CD009336.","journal-title":"Cochrane Database Syst Rev"},{"issue":"44","key":"2502_CR10","first-page":"11","volume":"13","author":"JM Smith","year":"2013","unstructured":"Smith JM, Gubin R, Holston MM, Fullerton J, Prata N. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date. BMC Pregnancy Childbirth. 2013;13(44):11.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"2502_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3329\/jhpn.v29i2.7812","volume":"29","author":"N Prata","year":"2011","unstructured":"Prata N, Passano P, Rowen T, Bell S, Walsh J, Potts M. Where there are (few) skilled birth attendants. J Health Popul Nutr. 2011;29(2):81\u201391.","journal-title":"J Health Popul Nutr"},{"issue":"3","key":"2502_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijgo.2009.12.003","volume":"108","author":"H Sanghvi","year":"2010","unstructured":"Sanghvi H, Ansari N, Prata NJV, Gibson H, Ehsan AT, Smith JM. Prevention of postpartum hemorrhage at home birth in Afghanistan. Int J Gynecol Obstet. 2010;108(3):276\u201381.","journal-title":"Int J Gynecol Obstet"},{"key":"2502_CR13","doi-asserted-by":"crossref","unstructured":"Weeks AD, Ditai J, Ononge S, Faragher B, Frye LJ, Durocher J, et al. The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial. BMC Pregnancy Childbirth. 2015;15:219.","DOI":"10.1186\/s12884-015-0650-9"},{"issue":"8","key":"2502_CR14","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/17441692.2017.1303743","volume":"13","author":"K Hobday","year":"2018","unstructured":"Hobday K, Hulme J, Belton S, Homer CSE. Community-based misoprostol for the prevention of post-partum haemorrhage: a narrative review of the evidence base, challenges and scale-up. Glob PUBLIC Health. 2018;13(8):1081\u201397.","journal-title":"Glob PUBLIC Health"},{"issue":"3","key":"2502_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/1471-0528.12447","volume":"121","author":"S Geller","year":"2014","unstructured":"Geller S, Carnahan L, Akosah E, Asare G. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana. BJOG Int J Obstet Gynaecol. 2014;121(3):319\u201326.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"2","key":"2502_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijgo.2014.05.016","volume":"127","author":"JM Smith","year":"2014","unstructured":"Smith JM, Dimiti A, Dwivedi V, Ochieng I, Dalaka M, Currie S, et al. Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan. Int J Gynecol Obstet. 2014;127(2):183\u20138.","journal-title":"Int J Gynecol Obstet"},{"issue":"189","key":"2502_CR17","first-page":"10","volume":"14","author":"JM Smith","year":"2014","unstructured":"Smith JM, Baawo SD, Subah M, Sirtor-Gbassie V, Howe CJ, Ishola G, et al. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia. BMC Pregnancy Childbirth. 2014;14(189):10.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"2502_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijgo.2015.10.018","volume":"133","author":"LM Vallely","year":"2016","unstructured":"Vallely LM, Homiehombo P, Walep E, Moses M, Tom M, Kelly-Hanku A, et al. Feasibility and acceptability of clean birth kits containing misoprostol for self-administration to prevent postpartum hemorrhage in rural Papua New Guinea. Int J Gynecol Obstet. 2016;133(3):301\u20136.","journal-title":"Int J Gynecol Obstet"},{"key":"2502_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/IJWH.S58638","volume":"6","author":"A Bazzano","year":"2014","unstructured":"Bazzano A, Ngo T, Jones L. Stakeholder perceptions of misoprostol: a qualitative investigation. Int J Women's Health. 2014;6:389.","journal-title":"Int J Women's Health"},{"issue":"s1","key":"2502_CR20","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1111\/jmwh.12154","volume":"59","author":"SA Spangler","year":"2014","unstructured":"Spangler SA, Gobezayehu AG, Getachew T, Sibley LM. Interpretation of National Policy Regarding Community-Based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions. J Midwifery Womens Health. 2014;59(s1):S83\u201390.","journal-title":"J Midwifery Womens Health"},{"issue":"1","key":"2502_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijgo.2013.10.004","volume":"125","author":"F Coeytaux","year":"2014","unstructured":"Coeytaux F, Hessini L, Ejano N, Obbuyi A, Oguttu M, Osur J, et al. Facilitating women\u2019s access to misoprostol through community-based advocacy in Kenya and Tanzania. Int J Gynecol Obstet. 2014;125(1):53\u20135.","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"2502_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/heapol\/czv012","volume":"31","author":"HJ Smith","year":"2016","unstructured":"Smith HJ, Colvin CJ, Richards E, Roberson J, Sharma G, Thapa K, et al. Programmes for advance distribution of misoprostol to prevent post-partum haemorrhage: a rapid literature review of factors affecting implementation. Health Policy Plan. 2016;31(1):102\u201313.","journal-title":"Health Policy Plan"},{"key":"2502_CR23","doi-asserted-by":"crossref","unstructured":"Collins L, Mmari K, Mullany LC, Gruber CW, Favero R. An exploration of village-level uterotonic practices in Fenerive-Est, Madagascar. BMC Pregnancy Childbirth. 2016;16:69.","DOI":"10.1186\/s12884-016-0858-3"},{"issue":"s1","key":"2502_CR24","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1111\/jmwh.12136","volume":"59","author":"LM Sibley","year":"2014","unstructured":"Sibley LM, Spangler SA, Barry D, Tesfaye S, Desta BF, Gobezayehu AG. A regional comparison of distribution strategies and Women\u2019s awareness, receipt, and use of misoprostol to prevent postpartum hemorrhage in rural Amhara and Oromiya regions of Ethiopia. J Midwifery Womens Health. 2014;59(s1):S73\u201382.","journal-title":"J Midwifery Womens Health"},{"issue":"1","key":"2502_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2011.10.005","volume":"116","author":"A Starrs","year":"2012","unstructured":"Starrs A, Winikoff B. Misoprostol for postpartum hemorrhage: moving from evidence to practice. Int J Gynecol Obstet. 2012;116(1):1\u20133.","journal-title":"Int J Gynecol Obstet"},{"issue":"3","key":"2502_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijgo.2009.11.006","volume":"108","author":"S Rajbhandari","year":"2010","unstructured":"Rajbhandari S, Hodgins S, Sanghvi H, McPherson R, Pradhan YV, Baqui AH. Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal. Int J Gynecol Obstet. 2010;108(3):282\u20138.","journal-title":"Int J Gynecol Obstet"},{"key":"2502_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12884-017-1347-z","volume":"17","author":"SP Rajbhandari","year":"2017","unstructured":"Rajbhandari SP, Aryal K, Sheldon WR, Ban B, Upreti SR, Regmi K, et al. Postpartum hemorrhage prevention in Nepal: a program assessment. BMC Pregnancy Childbirth. 2017;17:169.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"2502_CR28","doi-asserted-by":"publisher","first-page":"e0150739","DOI":"10.1371\/journal.pone.0150739","volume":"11","author":"K Jordan","year":"2016","unstructured":"Jordan K, Butrick E, Yamey G, Miller S. Barriers and facilitators to scaling up the non-pneumatic anti-shock garment for treating obstetric hemorrhage: a qualitative study. PLoS One. 2016;11(3):e0150739 Roy JK, editor.","journal-title":"PLoS One"},{"issue":"1","key":"2502_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12978-017-0383-5","volume":"14","author":"AABA Samnani","year":"2017","unstructured":"Samnani AABA, Rizvi N, Ali TS, Abrejo F. Barriers or gaps in implementation of misoprostol use for post-abortion care and post-partum hemorrhage prevention in developing countries: a systematic review. Reprod Health. 2017;14(1):1\u201310.","journal-title":"Reprod Health"},{"key":"2502_CR30","doi-asserted-by":"publisher","unstructured":"Risk factors and interventions associated with major primary postpartum hemorrhage unresponsive to first-line conventional therapy - MOUSA - Acta Obstet Gynecol Scand. 2008. Available from: \n                    https:\/\/doi.org\/10.1080\/00016340802087660\n                    \n                  . Wiley Online Library. Cited 2019 May 28.","DOI":"10.1080\/00016340802087660"},{"key":"2502_CR31","first-page":"10","volume":"7","author":"A Dumont","year":"2017","unstructured":"Dumont A, Bodin C, Hounkpatin B, Popowski T, Traor\u00e9 M, Perrin R, et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali. BMJ Open. 2017;7:10.","journal-title":"BMJ Open"},{"issue":"3","key":"2502_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijgo.2016.04.002","volume":"133","author":"E Wells","year":"2016","unstructured":"Wells E, Coeytaux F, Azasi E, Danmusa S, Geressu T, McNally T, et al. Evaluation of different models of access to misoprostol at the community level to improve maternal health outcomes in Ethiopia, Ghana, and Nigeria. Int J Gynecol Obstet. 2016;133(3):261\u20135.","journal-title":"Int J Gynecol Obstet"},{"key":"2502_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.socscimed.2014.09.046","volume":"121","author":"N Spicer","year":"2014","unstructured":"Spicer N, Bhattacharya D, Dimka R, Fanta F, Mangham-Jefferies L, Schellenberg J, et al. \u201cScaling-up is a craft not a science\u201d: Catalysing scale-up of health innovations in Ethiopia, India and Nigeria. Soc Sci Med. 2014;121:30\u20138.","journal-title":"Soc Sci Med"},{"key":"2502_CR34","volume-title":"Quasi-experimentation: Design & Analysis Issues for field settings","author":"T Cook","year":"1979","unstructured":"Cook T, Campbell D. Quasi-experimentation: Design & Analysis Issues for field settings. Houghton Mifflin: Boston; 1979."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2502-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-019-2502-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2502-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T23:10:43Z","timestamp":1603408243000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-019-2502-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2502"],"URL":"https:\/\/doi.org\/10.1186\/s12884-019-2502-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The evaluation protocol was approved by the Niger Ministry of Health National Ethical Committee on March 24th, 2016 (Approval number: 006\/2016\/CCNE). Administrative permission from the Ministry of Health was also obtained prior to implementing monitoring and evaluation activities at each public health facility in the evaluation sample. Written informed consent was obtained from all study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}